Striking study results last year indicated a new type of medicine may improve on Merck’s dominant immunotherapy, spurring a ...

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

A recent CNN report cast a spotlight on Akeso, a Chinese biotech company whose immunotherapy ivonescimab drug, now in ...

AstraZeneca and Daiichi Sankyo's Enhertu has become the first HER2-directed drug to mount a patient survival benefit in a ...

The Jha brothers are accused of trafficking in various falsified medicines, including knock-offs of Merck & Co's Keytruda.